0001140361-22-039283.txt : 20221101 0001140361-22-039283.hdr.sgml : 20221101 20221101080042 ACCESSION NUMBER: 0001140361-22-039283 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20221029 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Material Impairments ITEM INFORMATION: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20221101 DATE AS OF CHANGE: 20221101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DENTSPLY SIRONA Inc. CENTRAL INDEX KEY: 0000818479 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] IRS NUMBER: 391434669 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-16211 FILM NUMBER: 221348552 BUSINESS ADDRESS: STREET 1: 13320 BALLANTYNE CORPORATE PLACE CITY: CHARLOTTE STATE: NC ZIP: 28277-3607 BUSINESS PHONE: 844-546-3722 MAIL ADDRESS: STREET 1: 13320 BALLANTYNE CORPORATE PLACE CITY: CHARLOTTE STATE: NC ZIP: 28277-3607 FORMER COMPANY: FORMER CONFORMED NAME: DENTSPLY INTERNATIONAL INC /DE/ DATE OF NAME CHANGE: 19930630 FORMER COMPANY: FORMER CONFORMED NAME: GENDEX CORP DATE OF NAME CHANGE: 19920703 8-K 1 brhc10043485_8k.htm 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

October 29, 2022
Date of Report (Date of earliest event reported)

DENTSPLY SIRONA Inc.
(Exact name of registrant as specified in its charter)

Delaware
0-16211
39-1434669
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

13320 Ballantyne Corporate Place, Charlotte, North Carolina
28277-3607
(Address of principal executive offices)
(Zip Code)

(844) 848-0137
(Registrant's telephone number, including area code)

N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.01 per share
XRAY
The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02.
Results of Operations and Financial Condition.
 
On November 1, 2022, DENTSPLY SIRONA Inc. (the “Company”) issued a press release announcing the completion of the previously disclosed internal investigation into certain financial reporting matters and determination to restate the Company’s consolidated financial statements and related disclosures for the three and nine months ended September 30, 2021 and for the fiscal year ended December 31, 2021, as described in Item 4.02 herein.  The press release also includes preliminary unaudited information  about the Company’s expected results for the third quarter ended September 30, 2022, which may be subject to change. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is hereby incorporated by reference.
 
The information furnished pursuant to Item 2.02 in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference into any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.
 
Item 2.06.
Material Impairments.
 
The Company has continued to monitor macroeconomic events after its most recent annual goodwill impairment testing which was completed during the second quarter ended June 30, 2022. In the Company’s press release referenced in Item 2.02, the Company announced that it expects to record a non-cash charge related to impairment of its goodwill and intangible assets for the nine months ended September 30, 2022, due primarily to unfavorable macroeconomic factors such as a higher cost of capital, cost inflation, unfavorable foreign currency impacts, and increased supply chain costs, which are contributing to reduced forecasted revenues, lower operating margins and reduced expectations for future cash flows. The Company estimates that the pre-tax non-cash goodwill and intangible assets impairment charge will be between $1.0 billion and $1.3 billion.
 
Item 4.02.
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.
 
Restatements of Three and Nine Months Ended September 30, 2021 and Fiscal Year Ended December 31, 2021
 
On October 29, 2022, the Company, in consultation with the Audit and Finance Committee of its Board of Directors (the “Audit and Finance Committee”), reached a determination that the Company’s consolidated financial statements and related disclosures for the three and nine months ended September 30, 2021 and for the fiscal year ended December 31, 2021 should no longer be relied upon because of certain misstatements contained in those financial statements. The Company has determined that it is appropriate to correct the misstatements in the Company’s previously issued financial statements by amending its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2021 (the “Third Quarter 2021 Form 10-Q”) and its Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the “2021 Form 10-K”). The Audit and Finance Committee and management also discussed this conclusion with the Company’s independent registered public accounting firm, PricewaterhouseCoopers LLP (“PwC”).
 
As previously disclosed, the Audit and Finance Committee has been conducting an internal investigation into certain financial reporting matters. That investigation has been completed, and the results are discussed below in this Item 4.02. As a result of a separate but concurrent review by the Company of the accounting for various customer incentive arrangements unrelated to the transactions subject to the internal investigation (the “Accounting Review”), management identified errors related to certain customer incentive programs.  During the Accounting Review, it was also determined that the Company utilized incorrect accounting and assumptions in the determination of estimates related to its sales returns provisions, warranty reserve provisions and variable consideration. Management identified misstatements for the three and nine months ended September 30, 2021 and for the fiscal year ended December 31, 2021, in each case, that the Company deemed to be material when considered together with certain qualitative and quantitative considerations such as the fact that the misstatements masked a failure to meet internal financial targets and external financial analyst expectations for the three months ended September 30, 2021 and due to the material weaknesses identified through the course of the Audit and Finance Committee’s investigation.
 
Audit and Finance Committee Investigation

North America Investigation

On May 10, 2022, the Company announced that the Audit and Finance Committee, assisted by independent legal counsel and forensic accountants, commenced an internal investigation in March 2022 of allegations regarding certain financial reporting matters submitted by current and former employees of the Company. The Audit and Finance Committee’s investigation was focused on the Company’s use of incentives to sell products to certain distributors in North America in the third and fourth quarters of 2021, whether those incentives were appropriately accounted for, and whether the impact of the sales to which they were applied were adequately disclosed in the Company’s periodic reports filed with the Securities and Exchange Commission (“SEC”). The Audit and Finance Committee also investigated allegations that certain former members of senior management may have directed the Company’s use of these incentives and other actions to achieve executive compensation targets in 2021. We refer to this portion of the Audit and Finance Committee investigation as the North America Investigation.

In the North America Investigation, the Audit and Finance Committee concluded that there was no evidence of intentional wrongdoing or fraud. The Audit and Finance Committee determined that certain former members of senior management, including the Company’s former Chief Executive Officer and former Chief Financial Officer, violated provisions of the Company’s Code of Ethics and Business Conduct. In addition, these former members of senior management did not maintain and promote an appropriate control environment focused on compliance in areas of the Company’s business, nor did they sufficiently promote, monitor or enforce adherence to the Code of Ethics and Business Conduct. The North America Investigation found that certain former members of senior management, including the former Chief Executive Officer and the former Chief Financial Officer created a culture where employees did not feel comfortable raising concerns without fear of retaliation. In addition, the North America Investigation substantiated certain allegations regarding inappropriate tone at the top by the former Chief Executive Officer and the former Chief Financial Officer.

The North America Investigation identified instances in which the Company’s distributors in North America were offered incremental incentives, including extended payment terms, to purchase products in order for the Company to attempt to meet certain internal sales targets in the third and fourth quarters of 2021. These incentives were offered in conjunction with net sales transactions amounting to approximately $38 million and $70 million in the third and fourth quarters of 2021, respectively, which in turn contributed to higher levels of distributor inventory at the end of such periods, and lower sales to these distributors in the first and second quarters of 2022. The North America Investigation’s analysis of the incremental incentives and related sales, which included examination of documents supporting the accounting and revenue recognition for both the incentives and related sales, identified two insignificant accrual errors. However, these incremental incentives and the sales to which they applied contributed to the Company’s ability to meet external financial analyst expectations in the third quarter of 2021. The North America Investigation also found that there were inadequate processes in place for approval of these incentives and that the Company also had inadequate processes for maintaining or providing copies of agreements or arrangements with distributors to the accounting department. The North America Investigation noted potential omissions in public disclosures made by the Company regarding the use of these incentives or their potential future impacts in the third and fourth quarters of 2021. However, the North America Investigation did not find evidence that the former Chief Executive Officer and former Chief Financial Officer specifically directed the Company’s use of incentives to achieve executive compensation targets in 2021. Additionally, the investigation noted that the Company’s independent registered accounting firm was not informed of these incremental incentive arrangements in conjunction with the 2021 audit of the consolidated financial statements. Finally, the North America Investigation also identified findings regarding potential control deficiencies.

Based on the results of the North America Investigation, the Company further analyzed these product shipments and corresponding incentive arrangements between the Company and its distributors and determined that, with the exception of the errors pertaining to the Accounting Review described above, sales were properly recorded in each of the respective periods in accordance with ASC 606, Revenue from Contracts with Customers.

China Investigation

While the North America Investigation was ongoing, the Audit and Finance Committee was informed in June 2022 that the Company had identified higher returns of products from distributors in China during the fourth quarter of 2021 that did not align with historical trends identified through an operational audit executed by the Company’s Corporate Audit department.  Accordingly, the Audit and Finance Committee determined that the scope of the internal investigation should be expanded to analyze the increase in returns of products in China during the fourth quarter of 2021. We refer to this portion of the Audit and Finance Committee investigation as the China Investigation.

The China Investigation found that the Company processed returns and/or exchanges that were not in accordance with the return and/or exchange provisions contained in existing distributor agreements and sales contracts in China. The China Investigation also found that members of the Company’s local commercial team in China failed to provide information requested by the Company’s local accounting organization in connection with the return and/or exchange of products in China during the fourth quarter of 2021. The China Investigation concluded that these employees, as well as the head of the Company’s Asia-Pacific commercial organization, committed intentional wrongdoing by failing to provide requested information to the Company’s local accounting organization, by obstructing the work of the accounting team, and by lacking truthfulness in providing information to the Company and to the Audit and Finance Committee as part of the China Investigation. The China Investigation also determined that these actions by certain members of the Company’s local commercial team in China, as well as the former Chief Financial Officer and the head of the Company’s Asia-Pacific commercial organization, violated the Company’s Code of Ethics and Business Conduct. These employees, including the head of the Company’s Asia-Pacific commercial organization, also did not maintain and promote an appropriate control environment in certain areas of the Company’s business focused on compliance, nor did they sufficiently promote, monitor or enforce adherence to the Company’s Code of Ethics and Business Conduct. The China Investigation also identified concerns regarding control deficiencies, including ineffective communication among the China commercial operations, financial planning & analysis and accounting teams, resulting in a heightened risk of incomplete or insufficient information required to maintain accurate books and records related to incentive provisions, specifically concerning expanded concessions regarding the return or exchange of products from distributors.

The failure to appropriately account for these returns and/or exchanges and allowing for the product exchanges referred to above resulted in an overstatement of Net sales in the third quarter of 2021 of approximately $4 million which should have been recorded in the fourth quarter of 2021, which will be reflected in the restated interim financial statements for the three and nine month periods ended September 30, 2021.

As previously disclosed, the Company voluntarily contacted the SEC to advise that the Audit and Finance Committee was conducting an internal investigation regarding certain financial reporting matters and is continuing to cooperate with the staff of the SEC. While the amended Third Quarter 2021 Form 10-Q (“Form 10-Q/A”) and amended 2021 Form 10-K (“Form 10-K/A”) will address all of the issues identified in the Audit and Finance Committee investigation and the Accounting Review, the SEC’s investigation is ongoing, and there can be no assurance that there will not be additional issues or matters arising from that investigation.

Preliminary Estimated Impact of Misstatements
 
Restatement of financial statements included in the Third Quarter 2021 Form 10-Q
 
As a result of the items noted above, combined with certain other previously identified and out-of-period errors, Net sales and Net income in the Third Quarter 2021 Form 10-Q were overstated for the nine-month period ended September 30, 2021 by approximately $35 million and $27 million, respectively. These amounts are preliminary and may be subject to change.

The Company expects to file a Form 10-Q/A to restate its interim financial statements for the three and nine months ended September 30, 2021, and revise its interim financial statements for the three and nine months ended September 30, 2020, included in its Third Quarter 2021 Form 10-Q to reflect these corrections and other updates.

Restatement of financial statements included in the 2021 Form 10-K

As a result of the items noted above, combined with certain other previously identified and out-of-period errors, the Company determined that Net sales and Net income were overstated in the Company's financial statements for the fiscal year ended December 31, 2021 by approximately $20 million and $10 million, respectively, and there were immaterial errors to both Net sales and Net income (loss) for the fiscal years ended December 31, 2020 and 2019. Additionally, the correction of errors pertaining to periods prior to fiscal year 2019 required an adjustment to decrease opening retained earnings at January 1, 2019 by $38 million as reflected in the Consolidated Statements of Equity in its 2021 Form 10-K. Those errors related primarily to the timing, recognition, and estimation of variable consideration associated with certain sales transactions in the historical periods. These amounts are preliminary and may be subject to change.

The Company expects to file a Form 10-K/A to restate its 2021 financial statements, and revise its 2020 and 2019 financial statements included in its 2021 Form 10-K to reflect these corrections and other updates to its consolidated financial statements for the years ended December 31, 2021, 2020 and 2019.

Adjustments to the previously furnished Preliminary First Quarter 2022 and Second Quarter 2022 Financial Information

The Company previously provided preliminary financial results for each of the quarters ended March 31, 2022 and June 30, 2022 as furnished within the Current Reports on Form 8-K on May 10, 2022 and August 4, 2022, respectively. As a result of the Accounting Review and other error corrections noted above, these preliminary results will be adjusted for immaterial amounts in the upcoming filings of the Quarterly Reports on Form 10-Q for each of these quarters.

Controls and Procedures
 
In connection with the restatement of the financial statements and related disclosures for the three and nine months ended September 30, 2021 and for the fiscal year ended December 31, 2021, management re-evaluated the effectiveness of the Company’s internal control over financial reporting and identified one or more material weaknesses in the Company’s internal control over financial reporting as of September 30, 2021. These material weaknesses remained in place as of December 31, 2021 and as of the date of this Current Report on Form 8-K.
 
The Form 10-Q/A will amend management’s assessment of the Company’s disclosure controls and procedures to conclude that they were not effective due to the identification of one or more material weaknesses as of September 30, 2021. The Form 10-K/A will amend management’s assessment of the Company’s internal control over financial reporting and its disclosure controls and procedures due to the identification of one or more material weaknesses to indicate that its internal control over financial reporting and disclosure controls and procedures were not effective as of December 31, 2021. In addition, the Company’s independent registered public accounting firm, PwC, will amend its Report of Independent Registered Public Accounting Firm included in the Form 10-K/A to reflect that the Company’s internal control over financial reporting was not effective due to the identification of one or more material weaknesses in the Company’s internal control over financial reporting as of December 31, 2021.
 
The Company’s management has started to implement certain enhancements and remedial measures to its internal control over financial reporting and disclosure controls and procedures. Management will continue to evaluate the processes, procedures and controls and will make any further changes as appropriate.

Forward Looking Statements

All statements in this Current Report on Form 8-K that do not directly and exclusively relate to historical facts constitute “forward-looking statements.” These statements represent current expectations and beliefs and no assurance can be given that the results described in such statements will be achieved. Such statements are subject to numerous assumptions, risks, uncertainties and other factors, including those described in the section titled “Risk Factors” in Dentsply Sirona’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and any amendment. No assurance can be given that any expectation, belief, goal or plan set forth in any forward-looking statement can or will be achieved, and readers are cautioned not to place undue reliance on such statements which speak only as of the date they are made. The Company does not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date of this Current Report on Form 8-K or to reflect the occurrence of unanticipated events.

Item 9.01.
Financial Statements and Exhibits

(d)
Exhibits

DENTSPLY SIRONA Inc. Press Release Regarding the Completion of Internal Investigation and Determination to Restate the Company’s consolidated financial statements for the three and nine months ended September 30, 2021 and for the fiscal year ended December 31, 2021, with Business Update and Select Preliminary Third Quarter 2022 Results Issued November 1, 2022


104
Cover Page Interactive Data File (embedded within the Inline XBRL Document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
DENTSPLY SIRONA Inc.




By:
/s/ Glenn G. Coleman


Glenn G. Coleman


Executive Vice President and Chief Financial Officer

Date: November 1, 2022


 EX-99.1 2 brhc10043485_ex99-1.htm EXHIBIT 99.1
Exhibit 99.1



Dentsply Sirona Completes Internal Investigation
Announces Restatements of Third Quarter 2021 and Full Year 2021 Financials
Reports Select Preliminary Third Quarter 2022 Results

CHARLOTTE, N.C., November 1, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or “the Company”) (Nasdaq: XRAY) today announced the completion of the previously disclosed internal investigation into certain financial reporting matters. The investigation was undertaken by the Audit and Finance Committee of the Dentsply Sirona Board of Directors (the “Audit and Finance Committee”). Its findings and the actions the Company is taking to address these findings and certain related financial reporting matters are discussed in a Current Report on Form 8-K (the “8-K”) filed by the Company today.

“The Audit and Finance Committee’s thorough process conducted along with independent counsel and advisors resulted in findings and conclusions which have the full support of the Board,” said Eric Brandt, Chairman of the Dentsply Sirona Board of Directors. “The Company has already taken decisive and meaningful steps to address the findings and is now implementing enhancements and remedial measures to ensure these issues are thoroughly resolved. With a management team that is committed to accountability, operational rigor and integrity, coupled with the remedial measures, the entire Dentsply Sirona organization can move forward focused on delivering long-term growth and value creation.”

Restatements of Third Quarter 2021 and Full Year 2021

As noted in the 8-K filed today, on October 29, 2022, the Company, in consultation with the Audit and Finance Committee, reached a determination that the Company’s consolidated financial statements and related disclosures for the three and nine months ended September 30, 2021, and for the fiscal year ended December 31, 2021, should no longer be relied upon because of certain misstatements contained in those financial statements. The Company has determined that it is appropriate to correct the misstatements in the Company’s previously issued financial statements by amending its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2021 (the “Third Quarter 2021 Form 10-Q/A”), and its Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the “2021 Form 10-K/A”). The Audit and Finance Committee and management also discussed this conclusion with the Company’s independent registered public accounting firm, PricewaterhouseCoopers LLP.

Controls and Procedures

In connection with the restatement of the financial statements and related disclosures in the Third Quarter 2021 Form 10-Q/A and the 2021 Form 10-K/A, management re-evaluated the effectiveness of the Company’s internal control over financial reporting and its disclosure controls and procedures and identified one or more material weaknesses in the Company’s internal control over financial reporting as of September 30, 2021. The material weaknesses remained in place as of December 31, 2021 and as of the date of the 8-K.

The Company’s management has started to implement certain enhancements and remedial measures to its internal control over financial reporting and disclosure controls and procedures. Management will continue to evaluate the processes, procedures and controls and will make any further changes as appropriate.

Goodwill Impairment

In the nine months ended September 30, 2022, the Company expects to record a pre-tax non-cash charge for the impairment of goodwill and intangible assets in the range of $1.0 billion - $1.3 billion, due primarily to macroeconomic factors such as higher cost of capital, cost inflation, unfavorable foreign currency impacts, and increased supply chain costs, which are contributing to reduced forecasted revenues, lower operating margins, and reduced expectations for future cash flows.

Select Preliminary Third Quarter 2022 Results and Fourth Quarter 2022 Revenue Outlook

On a preliminary basis, the Company expects that third quarter 2022 Net sales will be approximately $947 million (representing a slight decline in organic sales versus the prior year). Relative to the prior year period, these results reflect foreign exchange headwinds, global supply chain challenges, and softer volumes in the U.S. and China.

Based on expected demand trends and foreign exchange impacts, the Company expects sequential Net sales to decline low-single digits in the fourth quarter 2022. On a constant currency basis, the Company expects sequential Net sales to be flat or up low-single digits in the fourth quarter 2022.The Company will provide further information about its results and 2022 outlook assumptions on its third quarter earnings conference call.

The amounts set forth above are preliminary estimates. The Company is currently finalizing its results of operations for the third quarter ended September 30, 2022. These preliminary estimates are based solely on information available to management as of the date of this press release. The Company’s actual results may differ from these estimates due to the completion of its quarter-end closing procedures, final adjustments and developments that may arise or information that may become available between now and the time the Company’s financial results are finalized and included in its Form 10-Q for the three and nine month periods ended September 30, 2022.

The Company expects to announce its full third quarter 2022 financial results on or around November 9, 2022, and will host an earnings conference call to discuss these results at that time.

About Dentsply Sirona 
 
Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona’s headquarters is located in Charlotte, North Carolina. The Company’s shares are listed in the United States on Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products. 
 
Forward-Looking Statements

All statements in this press release that do not directly and exclusively relate to historical facts constitute “forward-looking statements.” These statements represent current expectations and beliefs and no assurance can be given that the results described in such statements will be achieved. Such statements are subject to numerous assumptions, risks, uncertainties and other factors, including those described in the section titled “Risk Factors” in Dentsply Sirona’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and any amendment. No assurance can be given that any expectation, belief, goal or plan set forth in any forward-looking statement can or will be achieved, and readers are cautioned not to place undue reliance on such statements which speak only as of the date they are made. The Company does not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.

Non-GAAP Financial Measures

The Company has provided certain measures in this press release that are not calculated in accordance with US GAAP and therefore represent Non-GAAP measures. These Non-GAAP measures may differ from those used by other companies and should not be considered in isolation from, or as a substitute for, measures of financial performance prepared in accordance with US GAAP. These Non-GAAP measures are used by the Company to measure its performance and may differ from those used by other companies.

Management believes that these Non-GAAP measures are helpful as they provide another measure of the results of operations, and are frequently used by investors and analysts to evaluate the Company’s performance exclusive of certain items that impact the comparability of results from period to period, and which may not be indicative of past or future performance of the Company.

Organic Sales
The Company defines "organic sales" as the reported net sales adjusted for: (1) net sales from acquired businesses recorded prior to the first anniversary of the acquisition, (2) net sales attributable to disposed businesses or discontinued product lines in both the current and prior year periods, and (3) the impact of foreign currency changes, which is calculated by translating current period net sales using the comparable prior period's currency exchange rates.

Contact Information

Investors:
Andrea Daley
VP, Investor Relations
+1-704-805-1293
InvestorRelations@dentsplysirona.com

Press:
Marion Par-Weixlberger
VP, Corporate Communications and PR
+43 676 848414588
marion.par-weixlberger@dentsplysirona.com


 EX-101.SCH 3 xray-20221029.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 xray-20221029_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name EX-101.PRE 5 xray-20221029_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 image00001.jpg begin 644 image00001.jpg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htm IDEA: XBRL DOCUMENT v3.22.2.2
Document and Entity Information
Oct. 29, 2022
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Oct. 29, 2022
Entity File Number 0-16211
Entity Registrant Name DENTSPLY SIRONA Inc.
Entity Central Index Key 0000818479
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 39-1434669
Entity Address, Address Line One 13320 Ballantyne Corporate Place
Entity Address, City or Town Charlotte
Entity Address, State or Province NC
Entity Address, Postal Zip Code 28277-3607
City Area Code 844
Local Phone Number 848-0137
Title of 12(b) Security Common Stock, par value $0.01 per share
Trading Symbol XRAY
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
XML 8 brhc10043485_8k_htm.xml IDEA: XBRL DOCUMENT 0000818479 2022-10-29 2022-10-29 false 0000818479 8-K 2022-10-29 DENTSPLY SIRONA Inc. DE 0-16211 39-1434669 13320 Ballantyne Corporate Place Charlotte NC 28277-3607 844 848-0137 false false false false Common Stock, par value $0.01 per share XRAY NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 1 22 1 false 0 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://dentsplysirona.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports brhc10043485_8k.htm brhc10043485_ex99-1.htm xray-20221029.xsd xray-20221029_lab.xml xray-20221029_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "brhc10043485_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "brhc10043485_8k.htm" ] }, "labelLink": { "local": [ "xray-20221029_lab.xml" ] }, "presentationLink": { "local": [ "xray-20221029_pre.xml" ] }, "schema": { "local": [ "xray-20221029.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 29, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "xray", "nsuri": "http://dentsplysirona.com/20221029", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10043485_8k.htm", "contextRef": "c20221029to20221029", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "role": "http://dentsplysirona.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc10043485_8k.htm", "contextRef": "c20221029to20221029", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dentsplysirona.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dentsplysirona.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dentsplysirona.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dentsplysirona.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dentsplysirona.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dentsplysirona.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dentsplysirona.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dentsplysirona.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dentsplysirona.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dentsplysirona.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dentsplysirona.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dentsplysirona.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dentsplysirona.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dentsplysirona.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dentsplysirona.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dentsplysirona.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dentsplysirona.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dentsplysirona.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dentsplysirona.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dentsplysirona.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dentsplysirona.com/role/DocumentAndEntityInformation" ], "xbrltype": "trueItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dentsplysirona.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dentsplysirona.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dentsplysirona.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dentsplysirona.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dentsplysirona.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dentsplysirona.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dentsplysirona.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 15 0001140361-22-039283-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-22-039283-xbrl.zip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end